Point and Counterpoint: Polatuzumab Vedotin in the Front-Line Therapy for Diffuse Large B- Cell Lymphoma
Thomas, Colin; Thapa, Sameep; McLaughlin, Connor; Halloran, Molly; and Pierluigi, Porcu, "Point and Counterpoint: Polatuzumab Vedotin in the Front-Line Therapy for Diffuse Large B- Cell Lymphoma" (2023). Department of Medical Oncology Faculty Papers. Paper 227.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
This article is the author's final published version in Frontiers in Oncology, Volume 12, Article number 1098375.
The published version is available at https://doi.org/10.3389/fonc.2022.1098375. Copyright © 2023 Thomas, Thapa, McLaughlin, Halloran and Porcu.